Fully Fund the Global Fund: Harm Reduction Brief
Joint briefing on harm reduction and the Global Fund replenishment by Harm Reduction International, EHRA, INPUD and the Global Fund Advocates Network. More
Calendar
Recent materials
Call for New Global Long-Acting Technologies CAB Members from Asian, Central African, Eastern European, MENA, and Latin American Countries
TAG and AfroCAB announce an expanded call for a new cross-disease LAT CAB focused on malaria, hepatitis C, and latent TB. Apply now! Applications accepted on a rolling basis. More
Sofosbuvir Case in Brazil
Sofosbuvir case in Brazil is well analysed in a new publication ’Access to Medicines and Vaccines: Implementing Flexibilities Under Intellectual Property Law’. More
New Report on TB, HIV and Viral Hepatitis Services for Refugees and Migrants Across the WHO European Region
How the international recommendations on effective TB, HIV and viral hepatitis services for refugees and migrants are implemented within national policies across the WHO European Region. More
HCV Models of Care – Moving Towards Elimination - Webinar Materials Now Available Online
Webinar hosted by the Hepatitis C Partnership for Control and Treatment (Hepatitis C PACT) in partnership with the WHO Regional Offices for the Western Pacific and South-East Asia. More
Innovations in HCV Diagnostics: Real-World Implementation - 4 Key Takeaways
Virtual satellite session at 2021 International Conference on Health and Hepatitis Care in Substance Users, chaired by Treatment Action Group, The Kirby Institute, UNSW Sydney, FIND, and INPUD. More
